Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sibbiopharm manufactures over thirty microbiological synthesis products used primarily in agriculture—such as feed additives and biological plant protection agents—and also supplies some products relevant to environmental applications. The company operates modern laboratory and production facilities with ISO-certified quality management systems. It collaborates with research institutes for new product development but does not appear to develop human pharmaceuticals or advanced biotherapeutics typical of biotech/pharma companies focused on drug discovery or clinical trials. Its main market presence appears to be Russia and select international markets across fifteen countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sibrite.